Page 5 - Small Molecules News Today

Lonza Group AG / Key word(s): Bond/Financing Lonza Prices CHF 400 Million Dual-Tranche Straight Bonds 06.11.2023 / 18...

As the COVID-19 pandemic scattered and isolated people, researchers across Virginia Tech connected for a data-driven collaboration seeking improved drugs to fight the disease and potentially many other illnesses.

Looking to learn more about the factors that contribute to longevity and aging gracefully? Listen to these five podcast episodes for longevity hacks.

Looking to learn more about the factors that contribute to longevity and aging gracefully? Listen to these five podcast episodes for longevity hacks.

In the dynamic realm of oncology, the use of small-molecule drugs continues to play a crucial role in the treatment of lung cancer.

Lonza Group AG / Key word(s): ExpansionLonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer 13.10.2023 / 08:00 CET/CEST The new cGMP filling line at Lonza’s Stein (CH) site will enable handling and filling of bioconjugates for commercial supply Expansion of fill...

We spoke to Professor Janet Hemingway, founding Director of iiCON and Professor of Tropical Medicine at Liverpool School of Tropical Medicine.

Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as $44.77 and last traded at $44.97, with a volume of 86933 shares. The stock had previously closed at $45.67. Analyst Upgrades and Downgrades Separately, HSBC assumed coverage on Lonza Group in a […]

PharmAla has recieved a positive First Office Action on its novel P-1 Molecule from the Patent Cooperation Treaty...

PCT Examiner Finds Molecule to be both Novel and Inventive VANCOUVER, British Columbia, Sept. 25, 2023 -- PharmAla Biotech Holdings Inc. , a biotechnology company focused on the research,...